COVID-19 outbreak
Coronavirus disease 2019 (COVID-19) is the infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
A pneumonia of unknown cause detected in Wuhan, China was first reported to the World Health Organization Country Office in China on 31 December 2019 and recognised as a pandemic on 11 March 2020.
Reported illnesses have ranged from mild symptoms to severe illness and death for confirmed COVID-19 cases.
More information: WHO, CDC, global cases.
Follow us on Google News for the latest updates on the coronavirus.
Common antibiotic may be helpful in fighting respiratory viral infections
A new, Yale-led study suggests that a range of respiratory viral infections—including COVID-19 and influenza—may be preventable or treatable with a generic antibiotic that is delivered to the nasal passageway.
Apr 22, 2024
0
85
Drug design at the atomic level to thwart COVID-19
Although COVID-19 has faded from the headlines, SARS-CoV-2—the coronavirus behind the pandemic—is still rampantly infecting people around the world. Public health officials fear as the virus continues to evolve, it will ...
Mar 13, 2024
0
53
New bioengineered protein design shows promise in fighting COVID-19
In the wake of the COVID-19 pandemic, scientists have been racing to develop effective treatments and preventatives against the virus. A recent scientific breakthrough has emerged from the work of researchers aiming to combat ...
Mar 14, 2024
0
157
Nanoparticles target multiple COVID variants through the twist in the spike protein
Teardrop-shaped particles designed to inactivate multiple strains of the SARS-CoV-2 virus could one day complement existing treatments for COVID-19, according to a new study led by researchers at the University of Michigan ...
Mar 19, 2024
0
51
People who are 'double jointed' may be at heightened risk of long COVID, says study
People who are "double-jointed," a condition formally known as generalized joint hypermobility, may be at heightened risk of long COVID, suggests a case-control study published in the open access journal BMJ Public Health.
Mar 19, 2024
0
256
Discovery of how COVID-19 virus replicates opens door to new antiviral therapies
A new study looking at the replication stage of the SARS-CoV-2 virus that causes COVID-19 reveals important mechanisms in its replication that could be the foundation for new antiviral therapies.
Apr 5, 2024
0
9
Researchers develop more broadly protective coronavirus vaccine
Scientists have been searching for the optimal coronavirus vaccine since the COVID-19 pandemic started. The mRNA vaccines developed through the federal government's "Operation Warp Speed" program were a massive innovation; ...
Apr 1, 2024
0
278
Study tracks shifts in student mental health during college
A four-year study by Dartmouth researchers captures the most in-depth data yet on how college students' self-esteem and mental health fluctuates during their four years in academia, identifying key populations and stressors ...
Mar 13, 2024
0
2
New study reveals insights into COVID-19 antibody response durability
Researchers at the Institute of Human Virology (IHV) at the University of Maryland School of Medicine have published a new study in the Journal of Infectious Diseases investigating the antibody response following SARS-CoV-2 ...
Mar 18, 2024
0
4
SARS-CoV-2 spike protein sensitizes nociceptors and evokes nociceptive behaviors
A study that investigated whether the spike protein of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) can sensitize nociceptors and promote pain-like behaviors in mice was presented at the 102nd General Session ...
Mar 19, 2024
0
0
COVID-19 viral load rebound can occur after VV116, nirmatrelvir-ritonavir
For patients with mild-to-moderate COVID-19, viral load rebound and symptom rebound can occur after a standard five-day course of treatment with VV116 or nirmatrelvir-ritonavir, according to a study published online March ...
Mar 20, 2024
0
0
Antibiotic resistance in treating UTIs highest in aged care facilities, researchers find
Urinary tract infections (UTIs) caused by E. coli from aged care facilities show higher resistance to antibiotics compared to cases collected from hospitals and the wider community, find researchers from UNSW Sydney.
Mar 21, 2024
0
0
Health workers fear it's profits before protection as CDC revisits airborne transmission
Four years after hospitals in New York City overflowed with COVID-19 patients, emergency physician Sonya Stokes remains shaken by how unprepared and misguided the American health system was.
Mar 21, 2024
0
0
Decreases in social disparities in air pollution during lockdown suggest the need for sustainable policies
Is everyone equally affected by environmental pollution? This is the essence of 'environmental justice,' a concept that originated in the United States during the 1970s. It revolves around the idea of ensuring fairness and ...
Mar 25, 2024
0
13
Motivations for travel nurses accepting temporary assignments go beyond the big pay boost
Travel nurses take short-term contracts that can require long commutes or temporarily living away from home. Time and again, they have to get used to new co-workers, new protocols and new workplaces.
Apr 1, 2024
0
0
COVID-19 antibody discovery could explain long COVID
UVA Health researchers have discovered a potential explanation for some of the most perplexing mysteries of COVID-19 and long COVID. The surprising findings could lead to new treatments for the difficult acute effects of ...
Mar 28, 2024
0
42
How B cells recognize new variants of SARS-CoV-2
B cells are part of the immune system's memory. Their memories of previous infections or vaccinations provide the template for antibodies that have a protective effect the next time they come into contact with a pathogen.
5 hours ago
0
1
Hope for treating autoimmune diseases: Researchers explore diagnostic role of the systemic inflammation index
A routine blood test that measures a patient's inflammation levels could improve the early diagnosis and management of a wide range of debilitating autoimmune diseases.
Apr 3, 2024
0
19